Nivolumab (Opdivo).

Subjects

Subjects :

THERAPEUTIC use of antineoplastic agents
BLADDER tumors
CISPLATIN
ANTINEOPLASTIC agents
PROGRAMMED death-ligand 1
TRANSITIONAL cell carcinoma
CANCER chemotherapy
DRUG approval
METASTASIS
NIVOLUMAB
PROGRESSION-free survival
OVERALL survival

Details

Language :

English

ISSN :

15398226

Volume :

13

Issue :

5

Database :

Complementary Index

Journal :

Targeted Therapies in Oncology

Publication Type :

Periodical

Accession number :

176733814